肝胆相照论坛

标题: 区域科学家的目标是治愈了未来三年乙肝 [打印本页]

作者: StephenW 时间: 2015-3-27 08:17 标题: 区域科学家的目标是治愈了未来三年乙肝

[attach]472755[/attach]Area scientists aim to cure hepatitis B over next three years

Scientists tackling hepatitis B

Four scientists and 16 of their staff and laboratory researchers have joined the Baruch S. Blumberg Institute in Buckingham, with the goal of developing breakthrough therapies for hepatitis B within the next three years. From left: Scientists Ying-Hsiu Su, Jinhong Chang, Timothy Block and Ju Tao Guo.

Posted: Thursday, March 26, 2015 5:30 pm | Updated: 8:03 pm, Thu Mar 26, 2015.

By Crissa Shoemaker DeBree For the BCT

More than a dozen scientists and researchers have joined the Baruch S. Blumberg Institute in Bucks County with the goal of finding a cure for hepatitis B or breakthrough therapies to treat the virus within three years.

“In the 12 years that I have been a member of the foundation’s board of directors, I have never been more optimistic that a cure is within reach," Joel Rosen, chairman of the Hepatitis B Foundation's board of directors, said in a statement. "It’s an exciting time for everyone involved.”

The new group includes institute president and longtime volunteer Timothy Block, as well as three other scientists who have dedicated themselves to finding new ways to treat the disease that chronically infects an estimated 240 million people worldwide, according to the World Health Organization.

"We're interested in looking for a cure," said Block, a resident of Doylestown, Pennsylvania, on Thursday. "Hepatitis C has been cured. We are now using the concept of a cure for the first time in hepatitis B. That's our goal — a cure for hepatitis B and for liver cancer."

The disease, which can lead to cirrhosis, liver failure or liver cancer, is caused by sharing needles, blood-to-blood contact or unprotected sex with an infected person, according to the foundation's website, hepb.org. Symptoms can include fever, fatigue, appetite loss, nausea and vomiting, although 69 percent of those infected have no symptoms. While it can affect anyone, people of Asian descent are at higher risk.

Joining Block are Bucks County scientists Jinhong Chang of Chalfont, Ju Tao Guo of Lansdale and Ying-Hsiu Su of Audubon, as well as 16 of their staff members and laboratory researchers. All come from Drexel University, where Block was a professor of microbiology and immunology at the school's College of Medicine.

Their addition nearly triples the research capacity of the Blumberg Institute, which is the research arm of the Hepatitis B Foundation. Both the foundation and the institute are in the Pennsylvania Biotechnology Center in Buckingham.

"The Blumberg Institute is fortunate to have attracted Tim Block and his colleagues, positioning the nonprofit institute to maintain its world-class stature in hepatitis research," virologist Tom Shenk, a Princeton University professor and member of the foundation's board of directors, said in a statement.

The group will build on recent developments in hepatitis B research — including some developed by Blumberg Institute scientists — to work on new treatments for the disease. Those breakthroughs include new screening methods to search for effective drugs, new hepatitis B treatments that seek to shut down the virus, a new biomarker that helps detect liver cancer, and a drug that has shown promising results in killing liver cancer cells in animal studies.

Block and his wife, Joan, along with friends Paul and Janine Witte, co-founded the Hepatitis B Foundation in 1991. It's the only national nonprofit organization dedicated solely to finding a cure for hepatitis B and improving the quality of life for those affected worldwide through research, education and patient advocacy. Joan Block, a registered nurse, is the foundation's executive director.

In 2003, the foundation formed the Institute for Hepatitis and Virus Research, which has become home to the largest group of nonprofit scientists working on treatments and a cure for hepatitis B and liver cancer. It was renamed in 2013 to honor Blumberg, a Bucks County scientist who won the Nobel Prize in medicine for the discovery — announced 50 years ago this month in a medical journal — of the hepatitis B virus. Blumberg was a founder of the institute and worked there until his death in 2011.

"Dr. Blumberg anticipated all of this," Block said. "He knew what we were trying to do scientifically. He, of course, anticipated a lot of the results that we're seeing. He wouldn't have guessed the business success. I don't think he ever thought about hepatitis B (research) as actually being an attractive investment."

Rising awareness of the disease — and the fact that it's a leading cause of liver cancer — has led to increased funding for research, Block said.

The biotechnology center, where much of the work is dedicated to researching liver diseases, last year received a $4.7 million federal grant to fund an expansion of the facility. And the Blumberg Institute is close to completing a $3 million campaign that will help pay for the expanding research staff, Block said. More researchers are expected to join the institute in the coming months, he said.

"There's a lot more interest nationally and internationally in hepatitis B," Block said. "There's money interest. The business community has declared hepatitis B a priority. The nation is declaring hepatitis B a priority. A lot of sun is shining on us at the moment."

作者: StephenW 时间: 2015-3-27 08:18

区域科学家的目标是治愈了未来三年乙肝

科学家解决乙肝

四个科学家和他们的工作人员和实验室的研究人员16加入了巴鲁克S. Blumberg的研究所白金汉宫，与未来三年内开发出具有突破性的治疗乙肝的目标。左起：科学家应修苏，张金红，蒂莫西座和鞠陶国。

发布时间：星期四，2015年3月26日下午5时半|更新时间：下午8时03分，周四2015年3月26日。

通过Crissa鞋匠DeBree对于BCT

十几科学家和研究人员参加了巴鲁克S. Blumberg的研究所雄鹿县与寻找治疗乙肝或突破性治疗在三年内把病毒的目的。

“在12年，我一直董事基金会的董事会成员，我从未像现在这样乐观地认为治愈指日可待，”乔尔·罗森，董事乙型肝炎基金会的董事会主席，在一份声明中说。 “这是一个激动人心的时刻，每个人都参与其中。”

新的组包括研究院院长和长期志愿者蒂莫西座，以及其他三个谁献身寻找新的方法来治疗本病的长期传染估计2.4亿人全世界科学家，根据世界卫生组织。

“我们感兴趣的是寻找治疗，”座，宾夕法尼亚州Doylestown，上周四的居民说。 “丙型肝炎已经治愈我们现在使用的是治愈首次在乙型肝炎这就是我们的目标的概念 - 一种治疗乙型肝炎和肝癌。”

这种疾病可导致肝硬化，肝衰竭或肝癌，是通过共用针头，血液到血液接触或无保护的性行为与感染者造成的，根据该基金会的网站上，hepb.org。症状包括发热，乏力，食欲不振，恶心，呕吐，尽管69％的感染者没有症状。虽然它可以影响任何人，亚裔人在更高的风险。

加盟座是雄鹿县科学家张金红的查尔方特，兰斯代尔的鞠陶国和奥杜邦的应修素，以及他们的工作人员和实验室的研究人员16。全部来自Drexel大学，在那里是座微生物学和免疫学在医学学校的学院教授。

他们除了近三倍的布隆伯格研究所，这是乙型肝炎基金会的研究机构的研究能力。无论是基础和研究所都在宾夕法尼亚州的生物技术中心的白金汉宫。

“该布隆伯格学院是幸运地吸引了蒂姆Block和他的同事们，定位非盈利性机构，以维持其世界级的身形在肝炎的研究，”病毒学家汤姆·申克，董事基金会的董事会普林斯顿大学教授和成员，在说声明。

该小组将建立在最近的事态发展在乙肝研究 - 包括一些由布隆伯格研究所的科学家研制 - 以工作为疾病的新疗法。这些突破包括新的筛选方法，以搜索有效的药物，已显示有希望的结果在动物研究中杀死肝癌细胞新乙型肝炎治疗寻求关闭病毒，新的生物标志物，可帮助检测肝癌，和药物。

Block和他的妻子琼，与朋友一起保罗和珍妮维特，共同创立了乙型肝炎基金会于1991年，是唯一的全国性的非营利组织，专门致力于找到一种治疗乙型肝炎和改善生活质量受影响全球通过研究，教育和病人宣传。琼座，一名注册护士，是该基金会的执行董事。

2003年，该基金会成立的研究所肝炎和病毒研究，这已成为家非营利的科学家正在研究治疗的最大群体，并治愈乙肝和肝癌。它改名在2013年兑现布隆伯格，雄鹿县科学家谁赢得了诺贝尔医学奖的发现 - 公布50年前这个月在医学杂志 - 乙肝病毒。布隆伯格是该研究所的创始人，在那里工作，直到他去世于2011年。

“布隆伯格博士预见了这一切，”座说。 “他知道我们在努力做科学的。当然，他，预计很多，我们现在看到的结果。他不会猜到了商业上的成功。我不认为他没有想过乙型肝炎（研究），按实际是一个有吸引力的投资“。

而事实上，这是肝癌的主要病因 - - 疾病的意识抬头，导致研究增加资金，座说。

生物技术中心，在那里大部分工作是致力于研究肝病，去年获得了4700000美元联邦拨款设施的扩张提供资金。而布隆伯格学院是接近完成300万美元的活动，将帮助支付不断扩大的科研人员，座说。更多的研究人员预计参加在未来几个月内院，他说。

“有很多的利益在国内和国际上乙肝，”座说。 “有金钱利益，商界已宣布乙肝的重点。该国是声明乙肝的重点。很多太阳是目前照耀着我们。”

作者: 战天斗hbv 时间: 2015-3-27 10:08

能不能再快点、1年ok？

作者: newchinabok 时间: 2015-3-27 10:11

郭海涛，郭菊涛团队，oncore的后台科研人员

作者: 疯一点好 时间: 2015-3-27 10:59

能在三年内搞定就已经是非常乐观的预测了，希望是一条非常靠谱的消息

作者: 阳光醉人 时间: 2015-3-27 11:26

本帖最后由阳光醉人于 2015-3-27 16:40 编辑

有11111

作者: newchinabok 时间: 2015-3-27 11:46

回复阳光醉人的帖子

不能这么说，南橘北枳，种子很好，但土壤不同

作者: tonychant 时间: 2015-3-27 12:23

看了半天没有看到实质性的药物出现，只是空喊口号而已！

作者: newchinabok 时间: 2015-3-27 12:41

回复 tonychant 的帖子

oncore药就是他们研发，2015-2017上临床

作者: 战天斗hbv 时间: 2015-3-27 12:52

newchinabok 发表于 2015-3-27 11:46
回复阳光醉人的帖子

不能这么说，南橘北枳，种子很好，但土壤不同

同意、中国人还是挺厉害的、国内大环境不好、国外很多大学都有中国人当教授、我说的教授可不是国内这种哦、懂得自然懂

作者: zgct 时间: 2015-3-27 15:43

回复阳光醉人的帖子

把困难讲的太乐观，3年？广告

作者: MP4 时间: 2015-3-27 15:55

战天斗hbv 发表于 2015-3-27 12:52
同意、中国人还是挺厉害的、国内大环境不好、国外很多大学都有中国人当教授、我说的教授可不是国内这种哦 ...

是你不懂装懂罢了

作者: 重韧 时间: 2015-3-27 16:17

中国科学家在美国研究乙肝的其实不少，就是木有回国罢了。。不管是哪国的，能搞定乙肝就是老大。

作者: 战天斗hbv 时间: 2015-3-27 18:46

zgct 发表于 2015-3-27 15:43
回复阳光醉人的帖子

把困难讲的太乐观，3年？广告

是不是广告不知道、是不是乐观不知道、反正目前TKM手上有最强的牌、一手好牌啊、

作者: 菲凡 时间: 2015-3-27 21:12

我宁愿再一次相信

作者: 高高山顶立 时间: 2015-3-27 22:20

我强迫我自己相信他们。中国人智商绝冠全球，不过在国内似乎无用武之地。在资本主义国家就如鱼得水。

作者: 咬牙硬挺 时间: 2015-3-28 11:49

感谢分享

作者: 战天斗hbv 时间: 2015-3-28 14:18

为什么都说是三年、tkm也说是三年、上次那个斯坦福教授也是、还在哪看到也是、why？不是一年、不是两年、不是四年、而独独是三年

作者: 东海岸 时间: 2015-3-28 19:24

感谢分享

作者: 9病成医 时间: 2015-3-28 19:35

有个期待总是好的。真正的科学工作者说话应该是严谨的。

作者: newchinabok 时间: 2015-3-28 20:01

新药开发，历来都是高风险，高投入，长周期，失败率高达95%，现在乐观叫盲目乐观

作者: x321 时间: 2015-3-29 00:14

未来的5％好飘渺，明天一觉醒来哪国科学家解决了这才好。美梦成真美梦成真

作者: zgct 时间: 2015-3-29 09:42

或许：欧美应该更好更快研发出好药，可以不需要一辈子吃西药，但那么快研制出来，中国人就不依赖了，没钱攒了，所以，先设计好攒钱步调，慢慢来出药，以上为纯个人商业博弈推测！

作者: zgct 时间: 2015-3-29 09:42

个人认为：患者领导的团队可以提速50倍！

作者: zgct 时间: 2015-3-29 09:43

可惜我们没有

作者: 齐欢畅2 时间: 2015-3-29 10:28

乐观其成，必须的。

作者: 一字 时间: 2015-3-29 16:25

乙人的超级市场是根本动力。相信未来几年乙肝病毒一定会被彻底攻克！

作者: liangzaizaia 时间: 2015-3-30 08:55

我觉得十年能出来就很不错了。。。

作者: newchinabok 时间: 2015-4-7 17:16

Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists

‘All-star’ researchers intend to develop breakthrough therapies for the viral liver infection within 3 years
HepB United

DOYLESTOWN, Pa. (March 2015) – The Baruch S. Blumberg Institute (www.blumberginstitute.org) has recruited a new team of nationally renowned scientists to focus exclusively on research to develop a cure for hepatitis B, a move that nearly triples its research capacity and has created the largest concentration of nonprofit scientists focusing solely on hepatitis B and liver cancer in the United States.

Four principal scientists – Drs. Timothy Block, Jinhong Chang, Ju Tao Guo and Ying-Hsiu Su – and 16 of their staff members and laboratory researchers joined the Baruch S. Blumberg Institute full-time on March 1. Establishing this first-rate scientific team of leading hepatitis B researchers lays the groundwork to support an aggressive plan to develop breakthrough therapies to combat the virus within the next three years.

“By bringing leading researchers in the field together at its headquarters, the Hepatitis B Foundation, through its research arm, the Baruch S. Blumberg Institute, is able to concentrate their joint efforts to finding new treatments and, ultimately, a cure,” said Joel Rosen, Chairman of the Foundation’s board. “In the twelve years that I have been a member of the foundation’s board of directors, I have never been more optimistic that a cure is within reach. It’s an exciting time for everyone involved.”

The researchers will build upon recent discoveries that have accelerated the momentum for developing a cure for hepatitis B and liver cancer. Those breakthroughs include the development of new screening methods to search for effective drugs, new ways to treat hepatitis B using different approaches to shut down the virus, a new blood biomarker that aids in the early detection of liver cancer, and a promising drug that selectively kills liver cancer cells in animal studies.

“This is an incredibly exciting time in hepatitis B research, with the field poised to develop a cure. The Blumberg Institute is fortunate to have attracted Tim Block and his colleagues, positioning the nonprofit institute to maintain its world-class stature in hepatitis research,” said Dr. Tom Shenk, one of the nation’s leading virologists, a professor at Princeton University, and a member of the Foundation’s Board of Directors.

Block co-founded the Hepatitis B Foundation and is the president of the Blumberg Institute. For years, he has donated his time to both nonprofit entities, working full-time as a professor of Microbiology and Immunology at Drexel University College of Medicine, where he was Director of the Drexel Institute for Biotechnology and Virology Research. He has left that post in order to dedicate all of his time and focus to the work of the Blumberg Institute.

“The years that we all have spent working towards a cure for hepatitis B have laid the groundwork for this final phase,” said Block. “We are committing everything we have, every resource at our disposal, to developing the therapies that will improve the lives of the millions of people worldwide who live with the hepatitis B virus every day, as well as the risk of dying prematurely from its most fatal consequence, liver cancer.”

With promising drugs in the research pipeline, the Hepatitis B Foundation and the Blumberg Institute have begun exploring relationships with companies that can take those discoveries from the lab to the clinic, where they can benefit people worldwide.

“The fact that Dr. Tim Block and other world-class scientists have chosen to join the Blumberg Institute in its drive to find a cure for hepatitis B speaks volumes about the Institute’s cutting-edge science and potential to impact global health,” said Wayne Yetter, former president and CEO of the multinational pharmaceutical company Novartis U.S. and a recent addition to the Hepatitis B Foundation’s Board of Directors.

In addition to the exciting implications for the world of science and medicine, the new jobs created at the Blumberg Institute are a welcome boost to the local and regional economy of Bucks County and southeast Pennsylvania.

"The Blumberg Institute's recruitment of four world-class scientists and their staff, including Dr. Timothy Block, is great news for this community,” said Bucks County state Sen. Charles McIlhinney, a longtime supporter of the organization. “The Blumberg Institute, which manages and is located at the Pennsylvania Biotechnology Center, has been responsible for breakthrough discoveries coupled with spectacular jobs and company creation, right here in Bucks County. This is the kind of growth we need.”

About the Hepatitis B Foundation: Headquartered in Doylestown, Pa., the Hepatitis B Foundation was founded in 1991 and is the only national nonprofit organization solely dedicated to finding a cure for hepatitis B and improving the quality of life for those affected worldwide through research, education and patient advocacy. To learn more, visit www.hepb.org.

About the Baruch S. Blumberg Institute: The Hepatitis B Foundation established an independent, nonprofit research institute in 2003 in order to conduct discovery research and nurture translational biotechnology in an environment conducive to interaction, collaboration and focus. The research center was renamed in 2013 to honor Baruch S. Blumberg, the man who won the Nobel Prize for his discovery of the hepatitis B virus. To learn more, visit www.blumberginstitute.org.

About the Pennsylvania Biotechnology Center: The Pennsylvania Biotechnology Center of Bucks County offers state-of-the-art laboratory and office space to nonprofit research companies and biotech companies. Created by a partnership between the Hepatitis B Foundation and Delaware Valley College, and managed by the Blumberg Institute, the Center was funded in part by the Commonwealth of Pennsylvania. The facility opened in 2006 in a formerly abandoned warehouse and has since grown to encompass 110,000 square feet on a 10-acre campus. To learn more, visit www.pabiotechbc.org.

# # #

作者: newchinabok 时间: 2015-4-7 17:17

http://www.hepb.org/news/release_3_30_2015.html

作者: newchinabok 时间: 2015-4-7 17:18

本帖最后由 newchinabok 于 2015-4-7 17:21 编辑

hbf 口号：All-star’ researchers intend to develop breakthrough therapies for the viral liver infection within 3 years

不是治愈，是breakthrough，

我也甩一下洋文

作者: HBVCURER 时间: 2015-4-7 23:24

本帖最后由 HBVCURER 于 2015-4-7 23:26 编辑

Block教授是业内著名的也是典型的美式“大忽悠”，他从前所发表的文章和所做的演讲无时不深刻体现着这一点

眼下搞得这个All-star team和3-year plan更是把这一特质发挥的淋漓尽致。
Hope for the best and prepare for the worst，我想无论是患者还是从业人员，都应该抱有这种心态。与大家共勉！

作者: x321 时间: 2015-4-8 01:16

原来是这样

作者: StephenW 时间: 2015-4-8 02:34

本帖最后由 StephenW 于 2015-4-8 16:06 编辑

HBF成立于1991年，由 Tim Block博士，他的妻子 Joan ，保罗和珍妮维特。
HBF是唯一和最古老一个致力于乙肝研究和病人的非盈利性组织。
他们的口号一直是“希望一个治愈” (Hope for a Cure).
HBF受益很多人，包括本论坛和我个人.
只是在过去12个月，Dr Block预测治愈HBV.

作者: 战天斗hbv 时间: 2015-4-8 05:17

HBVCURER 发表于 2015-4-7 23:24
Block教授是业内著名的也是典型的美式“大忽悠”，他从前所发表的文章和所做的演讲无时不深刻体现着这一点: ...

原来如此！

作者: 战天斗hbv 时间: 2015-4-8 05:29

本帖最后由战天斗hbv 于 2015-4-8 05:29 编辑

HBVCURER 发表于 2015-4-7 23:24
Block教授是业内著名的也是典型的美式“大忽悠”，他从前所发表的文章和所做的演讲无时不深刻体现着这一点: ...

HBVCURE兄、说说你对gs4774的看法吧！其公司最近股票飙得厉害

作者: newchinabok 时间: 2015-4-8 07:10

美式大忽悠，把这么多科学家忽悠在一起，并和oncore，tkmr忽悠全世界hbv患者，投资人，确实不简单

作者: zgct 时间: 2015-4-8 07:33

francis25 | 分类：传染科 | 浏览2025次
为什么美国那么多顶尖科学家，却研究不出好的抗乙肝病毒药？
是确实太难（智力问题）？是经费问题？
我认为都不是，因为假如真有人研究出来这种药，他会得诺贝尔奖，但资金才多少？这还不是主要原因，主要是美国人得这病的并不多，中国人得的多，对他们美国人没什么影响，所以就生产一些不能彻底清除乙肝病毒的药卖给中国人，而且要让他们产生依赖，所以就可以长期挣钱，源源不断的，这种抗病毒药挣一段时间钱，新的抗病毒药再挣一段时间钱，反正不可能给你完全治好病的药，谁发明这种药了，就损害了那些西医西药厂的长期利益，这些利益集团的老板会灭了这科学家的命。
我是这样认为的妙就妙在乙肝病毒不像爱滋病那样要命，不攻克而又能挣患者的钱，当然是最好的效果，要是攻克了那多少肝病科的医生多少西药药厂都要失业和倒闭。说白了，这个世界强势者的利益永远是第一位的，哪怕他们是禽兽，强盗，都有一张伪善的面孔中国的研究能力就别提了，众所周知，整出解决乙肝病毒的药比中国队得世界杯还难美国那边，我预言，再过10~20年都不会有突破性进展，只会有一种新抗病毒药替代另一种旧抗病毒药，循环捞钱，乐何如哉？现在就有突破性进展甚至灭绝乙肝病毒了，对利益集团有什么长远的好处？他们会那么傻？

作者: zgct 时间: 2015-4-8 07:37

6年前网上医生就作出上述预言了，悲伤！

作者: newchinabok 时间: 2015-4-8 07:44

上述想法不成立，制药公司之间也有博弈，有的公司也有一统江山的野心，否则就没有吉利德根治丙肝药

作者: hao2014 时间: 2015-4-8 09:52

zgct 发表于 2015-4-8 07:33
francis25 | 分类：传染科 | 浏览2025次
为什么美国那么多顶尖科学家，却研究不出好的抗乙肝病毒药？
是确 ...

这个典型的阴谋论加上大仙帖

说对了就吹牛

说错了反正也没人找他算账

作者: hao2014 时间: 2015-4-8 09:52

历史上很多著名人士都有过类似预约

现在只是一笑而已

作者: HBVCURER 时间: 2015-4-8 11:10

作为意见领袖，某些科学家必须要扮演“大忽悠”的角色，从而整合政府，科研机构，制药公司，投资人等多方多面的资源，推进研究的进程及产业化。这些人可以称为科学家中的政治家，而“大忽悠”在这里也未必是贬义词。

关于Block教授，业内有不少趣闻，他的报告我听过不少，也曾经在吃饭的时候听他的手下干将郭教授讲过一些故事。关于这个All-star team和3-year plan，郭教授自己是一笑置之。可能他相比Block教授性格更内敛一些，更谦虚谨慎吧

作者: HBVCURER 时间: 2015-4-8 11:13

战天斗hbv 发表于 2015-4-8 05:29
HBVCURE兄、说说你对gs4774的看法吧！其公司最近股票飙得厉害

GS4774本身没啥可说的，治疗性疫苗关键看佐剂，未来还需要配合其他的疗法才能达到最佳效果。

制药公司尤其是小公司在临床结果发布之前股票大涨或大跌都是正常现象，在结果发布之后大逆转也是家常便饭，个人觉得不必过度解读。

作者: 战天斗hbv 时间: 2015-4-8 13:27

HBVCURER 发表于 2015-4-8 11:13
GS4774本身没啥可说的，治疗性疫苗关键看佐剂，未来还需要配合其他的疗法才能达到最佳效果。

制药公司尤 ...

谢谢！

作者: StephenW 时间: 2015-4-8 16:04

回复 HBVCURER 的帖子

Haitao Guo PhD

Ju-Tao Guo MD

巴鲁克S. Blumberg的学院有两个郭，一个是博士，一个是MD。两者都是研究人员，是哪一个郭？

作者: newchinabok 时间: 2015-4-8 16:05

美国大忽悠下的干将

作者: HBVCURER 时间: 2015-4-8 16:19

StephenW 发表于 2015-4-8 16:04
回复 HBVCURER 的帖子

哈哈，这两个郭*涛教授，发paper几乎总是共同署名，开会也总在一起，本身同在一个大学/研究所，年纪差别不大，名字又极为接近，所以总会被人误认为是兄弟俩或是有啥亲戚关系。

All-star team里面的是后者，郭巨涛教授，出道早一些。

作者: luckable 时间: 2015-4-8 17:28

回复 StephenW 的帖子

在去年之前，他是怎么说的呀？什么叫区域科学家？请问StephenW

作者: luckable 时间: 2015-4-8 17:30

StephenW 发表于 2015-4-8 02:34
HBF成立于1991年，由 Tim Block博士，他的妻子 Joan ，保罗和珍妮维特。
HBF是唯一和最古老一个致力于乙肝 ...

在去年之前，他是怎么说的呀？什么叫区域科学家？请问StephenW

作者: StephenW 时间: 2015-4-8 17:42

回复 luckable 的帖子

"区域" - "本地".
因为消息是来自(Doylestown, USA)本地新闻, Doylestown记者使用“本地”的描述. 这些科学家都来自本地(Doylestown, USA).

之前, HBF(乙型肝炎基金会)口号是"希望一个治愈".

作者: luckable 时间: 2015-4-8 17:52

回复 StephenW 的帖子

还是挺让人心情愉快的一个报道，谢谢您

作者: crysalechain 时间: 2015-4-8 18:17

为什么总受愚弄？一次又一次的失望！
肝受伤已经很惨了，现在心也一起受伤！

作者: luckable 时间: 2015-4-8 19:12

回复 crysalechain 的帖子

每个人都不想失望，大家很理解你。但是现阶段还是要面对现实。就像HBVCURER说的，报最大的希望，做最坏的打算

作者: crysalechain 时间: 2015-4-10 07:20

回复 luckable 的帖子

我现在已经不再整日幻想了。活一天算一天。因为活着也好累

作者: x321 时间: 2015-4-14 09:30

本帖最后由 x321 于 2015-4-14 09:31 编辑

URLURLURL

欢迎光临肝胆相照论坛 (http://hbvhbv.info/forum/)